Design, synthesis and utility of novel benzophenone-containing calcitonin analogs for photoaffinity labeling the calcitonin receptor

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 2, 1997, Pages 876-884

  Suva, Larry J ^a,e   Flannery, Merrilee S ^b   Caulfield, Michael P ^c   Findlay, David M ^d   Jüppner, Harald ^b   Goldring, Steven R ^b   Rosenblatt, Michael ^a   Chorev, Michael ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^d ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BENZOPHENONE DERIVATIVE; CALCITONIN DERIVATIVE; CALCITONIN RECEPTOR; CYCLIC AMP; HEMAGGLUTININ; LEUCINE; LYSINE; VALINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DRUG SYNTHESIS; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; NONHUMAN; PHOTOAFFINITY LABELING; PHOTOLYSIS; PRIORITY JOURNAL; RADIOIODINATION;

AMINO ACID SEQUENCE; BENZOPHENONES; BINDING, COMPETITIVE; CALCITONIN; CYCLIC AMP; DRUG DESIGN; MOLECULAR SEQUENCE DATA; PHOTOAFFINITY LABELS; RECEPTORS, CALCITONIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030783874     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. ALBRANDT, K., MULL, E., BRADY, E. M. G., HERICH, J., MOORE, C. X. AND BEAUMONT, K.: Molecular cloning of two receptors from rat brain with high affinity for salmon calcitonin. FEBS Lett. 325: 225-232, 1993.
2. BERGWITZ, C., GARDELLA T. J., FLANNERY, M. R., POTTS, J. T. JR., KRONENBERG, H. M., GOLDRING, S. R. AND JÜPPNER H.: Full activation of chimeric receptors by hybrids between parathyroid hormone and calcitonin. J. Biol. Chem. 271: 26469-26472, 1996.
3. CHAKRABORTY, M., CHATTERJEE, D., KELLOKUMPU, S., RASMUSSEN, H. AND BARON, R.: Cell cycle-dependent coupling of the calcitonin receptor to different G proteins. Science 251: 1078-1082, 1991.
4. CHAMBERS, T. J. AND DUNN, C. J.: Pharmacological control of osteoclast motility. Calcif. Tissue Int. 35: 566-570, 1983.
5. CHAMBERS, T. J. AND MAGNUS, C. J.: Calcitonin alters behavior of isolated osteoclasts. J. Pathol. 136: 27-39, 1982.
6. CHAMBERS, T. J., MCSHEEHY, P. M. J., THOMPSON, B. M. AND FULLER, K.: The effect of calcium regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rat bones. Endocrinology 116: 234-239, 1985.
7. CHEN, Y. T., HOLCOMB, C. AND MOORE, H-P. H.: Expression and localization of two low molecular weight GTP-binding proteins Rab8 and Rab10 by epitope tag. Proc. Natl. Acad. Sci. U.S.A. 90: 6508-6512, 1993.
8. CHOREV, M., ROUBINI, E., MCKEE, R. L., GIBBONS, S. W., REAGAN, J. E., GOLDMAN, M. E., CAULFIELD, M. P. AND ROSENBLATT, M.: Biological activity of parathyroid hormone antagonists substituted at position 13. Peptides 12: 57-62, 1991.
9. CIVITELLI, R., GONNELLI, S., ZACCJEI, F., BIGAZZI, S., VATTIMO, A., AVIOLI, L. V. AND GENNARI, C.: Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J. Clin. Invest. 82: 1268-1274, 1988.
10. CZECH, M. P., CHAWLA, A., WOON, C-W., BUXTON, J., ARMONI, M., TANG, W., JOLY, M. AND CORVERA, S.: Exofacial epitope-tagged glucose transporter chimeras reveal COOH-terminal sequences governing cellular localization. J. Cell. Biol. 123: 127-135, 1993.
11. DORMAN, G. AND PRESTWICH, G. D.: Benzophenone photophores in biochemistry. Biochemistry 33: 5661-5673, 1994.
12. D'SANTOS, C. S., NICHOLSON, G. C., MOSELEY, J. M., EVANS, T., MARTIN, T. J. AND KEMP, B. E.: Biologically active, derivatizable salmon calcitonin analog: design, synthesis and applications. Endocrinology 123: 1483-1488, 1988.
13. EMRICH, T., FÖRSTER, R. AND LIPP, M.: Topological characterization of the lymphoid-specific seven transmembrane receptor BLR1 by epitope-tagging and high level expression. Biochem. Biophys. Res. Commun. 197: 214-220, 1993.
14. EPAND, R. M., EPAND, R. F. AND ORLOWSKI, R. C.: Presence of an amphipathic helical segment and its relationship to biological potency of calcitonin analogs. Int. J. Pept. Protein. Res. 25: 105-111, 1985.
15. EPAND, R. M., EPAND, R. F., ORLOWSKI, R. C., SCHLUETER, R. J., BONI, L. T. AND HUI, S. W.: Amphipathic helix and its relationship to the interaction of calcitonin with phospholipids. Biochemistry 22: 5074-5084, 1983.
16. FIELD, J., NIKAWA, J., BROEK, D., MACDONALD, B., RODGERS, L., WILSON, I. A., LERNER, R. A. AND WIGLER, M.: Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition complex. Mol. Cell. Biol. 8: 2159-2165, 1988.
17. FINDLAY, D. M., MICHELANGELI, V. P., EISMAN, J. A., FRAMPTON, R. J., MOSELEY, J. M., MACINTYRE, I., WHITEHEAD, R. AND MARTIN, T. J.: Calcitonin and 1,25-dihydroxy vitamin D3 receptors in human breast cancer cell lines. Cancer Res. 40: 1311-1317, 1980.
18. FINDLAY, D. M., MICHELANGELI, V. P., MARTIN, T. J., ORLOWSKI, R. C. AND SEYLER, J. K.: Conformational requirements for activity of salmon calcitonin. Endocrinology 117: 801-805, 1985.
19. GARDELLA, T. J., LUCK, M. D., FAN, M-H. AND LEE, C. W.: Transmembrane residues of parathyroid hormone (PTH)/PTH-related protein receptor that specifically affect binding and signaling by agonist ligands. J. Biol. Chem. 271: 12820-12825, 1996.
20. GELI, V., BATY, D. AND LAZDUNSKI, C.: Use of a foreign epitope as a "tag" for the localization of minor proteins within a cell: the case of the immunity protein to colicin A. Proc. Natl. Acad. Sci. U.S.A. 85: 689-693, 1988.
21. GOLDRING, S. R., DAYER, J-M., AUSIELLO, D. A. AND KRANE, S. M.: A cell strain cultured from porcine kidney increases cyclic AMP content upon exposure to calcitonin or vasopressin. Biochem. Biophys. Res. Commun. 83: 434-440, 1978.
22. GOLDRING, S. R., TYLER, G. A., KRANE, S. M., POTTS, J. T. JR. AND ROSENBLATT, M.: Photoaffinity labeling of parathyroid hormone receptors: comparison of receptors across species and target tissues after desensitization to hormone. Biochemistry 23: 498-502, 1984.
23. GORN, A. H., LIN, H. Y., YAMIN, M., AURIN, P. E., FLANNERY, M. R., MANNING, C. A., LODISH, H. F., KRANE, S. M. AND GOLDRING, S. R.: Cloning, characterization and expression of a human calcitonin receptor from an ovarian carcinoma cell line. J. Clin. Invest. 90: 1726-1735, 1992.
24. GREEN, F. R. III, LYNCH, B. AND KAISER, E. T.: Biological and physical properties of a model calcitonin containing a glutamate residue interrupting the hydrophobic face of the idealized amphiphilic alpha-helical region. Proc. Natl. Acad. Sci. U.S.A. 84: 8340-8344, 1987.
25. GRUBER, H. E., IVE, Y J. L., BAYLINK, D. J., MATTHEW, M., NELP, W. B., SISOM, K. AND CHESTNUT, C. H. III.: Long-term calcitonin therapy in post menopausal osteoporosis. Metab. Clin. Exp. 33: 295-303, 1984.
26. HOLTROP, N. E., RAISZ, L. G. AND SIMMONS, H. A.: The effects of parathyroid hormone, colchicine, and calcitonin on the ultrastructure and the activity of osteoclasts in organ culture. J. Cell. Biol. 60: 346-355, 1974.
27. HOUSSAMI, S., FINDLAY, D. M., BRADY, C. L., MARTIN, T. J. AND SEXTON, P. M.: Isoforms of the rat calcitonin receptor: consequences for ligand binding and signal transduction. Endocrinology 135: 183-190, 1994.
28. KARPF, D. B., ARNAUD, C. D., KING, K., BAMBINO, T., WINER, J., NYIREDY, K. AND NISSENSON, R. A.: The canine renal parathyroid hormone receptor is a glycoprotein: characterization and partial purification. Biochemistry 26: 7825-7833, 1987.
29. LIVESEY, S. A., COLLIER, G., ZAJAC, J. D., KEMP, B. E. AND MARTIN, T. J.: Characteristics of selective activation of cyclic AMP-dependent protein kinase isoenzymes by calcitonin and prostaglandin E2 in human breast cancer cells. Biochem. J. 224: 361-370, 1984.
30. LIN, H. Y., HARRIS, T. L., FLANNERY, M. S., ARUFFO, A., KAJI, E. H., GORN, A., KOLAKOWSKI, L. F. JR., LODISH, H. F., GOLDRING, S. R.: Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science 254: 1022-1024, 1991.
31. MAZZUOLI, G. F., PASSERI, M., GENNARI, C., MINISOLA, S., ANTONELLI, R., VALTORTA, C., PALUMMERI, E., CERVELLIN, G. F., GONNELLI, S. AND FRANCINI, G.: Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind study. Calcif. Tissue Int. 38: 3-8, 1986.
32. MOE, G. R. AND KAISER, E. T.: Design, synthesis and characterization of a model peptide having potent calcitonin-like biological activity: implications for calcitonin structure/activity. Biochemistry 24: 1971-1976, 1985.
33. MURAD, F., BREWER, H. B. JR. AND VAUGHAN, M.: Effect of thyrocalcitonin on adenosine 3′:5′-cyclic phosphate formation by rat kidney and bone. Proc. Natl. Acad. Sci. U.S.A. 65: 446-453, 1970.
34. NAKAMOTO, C., BEHAR, V., CHIN, K., ADAMS, A. E., SUVA, L. J., ROSENBLATT, M. AND CHOREV, M.: Probing the bimolecular interactions of parathyroid hormone (PTH) and the human PTH/PTHrP Receptor. I. Design, synthesis and characterization of photoreactive benzophenone-containing analogs of PTH. Biochemistry 34: 10546-10552, 1995.
35. PINES, M., ADAMS, A. E., STUECKLE, S., BESSALLE, R., RASHTI-BEHAR, V., CHOREV, M., ROSENBLATT, M. AND SUVA, L. J.: Generation and characterization of human kidney cell lines stably expressing recombinant human PTH/PTHrP receptor: lack of interaction with a C-terminal human PTH peptide. Endocrinology 135: 1713-1716, 1994.
36. QIAN, N-X., WINITZ, S. AND JOHNSON, G. L.: Epitope-tagged Gq alpha subunits: expression of GTPase-deficient alpha subunits persistently stimulates phosphatidylinositol-specific phospholipase C but not mitogen-activated protein kinase activity regulated by the M1 muscarinic acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A. 90: 4077-4081, 1993.
37. QUIZA, M., DOWTON, M., PERRY, K. J. AND SEXTON, P. M.: Electrophoretic mobility and characterization of heterogeneously expressed calcitonin receptors. Endocrinology 138: 530-539, 1997.
38. REGINSTER, J. Y., ALBERT, A., LECART, M. P., LAMBELIN, P., DENIS, D., DEROISY, R., FONTAINE, M. A. AND FRANCHIMONT, P.: 1-year controlled randomized trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet 2: 1481-1483, 1987.
39. RITTEL, W., MAIER, R., BRUGGER, M., KAMBER, B., RINIKER, B. AND SIEBER, P.: Structure-activity relationship of human calcitonin III. Biological activity of synthetic analogs with shortened or terminally modified peptide chains. Experientia 32: 246-248, 1976.
40. SEGRE, G. AND GOLDRING, S. R.: Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide (PTHrP), vasoactive intestinal peptide, glucagon-like peptide, growth hormone-releasing hormone and glucagon belong to a newly discovered G-protein-linked receptor family. Trends Endocrinol. Metab. 4: 309-314, 1993.
41. SEXTON, P. M., HOUSSAMI, S., HILTON, J. M., O'KEEFFE, L. M., CENTER, R. J., GILLESPIE, M. T., DARCY, P. AND FINDLAY, D. M.: Identification of brain isoforms of the rat calcitonin receptor. Mol. Endocrinol. 7: 815-821, 1993.
42. STROOP, S. D. AND MOORE, E. E.: Calcitonin persistently activates a receptor-operated calcium channel (Abstract). J. Bone Miner. Res. 9: Suppl. 1, S283, 1994.
43. STROOP, S. D., THOMPSON, D. L., KUESTNER, R. E. AND MOORE, E. E.: A recombinant human calcitonin receptor functions as an extracellular calcium sensor. J. Biol. Chem. 268: 19927-19930, 1993.
44. SUVA, L. J., ERNST, M. AND RODAN, G. A.: Retinoic acid increases zif268 early gene expression in rat pre-osteoblastic cells. Mol. Cell. Biol. 5: 2503-2510, 1991.
45. USDIN, T. B., GRUBER, C. AND BONNER, T. I.: Identification and functional characterization of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J. Biol. Chem. 270: 15455-15458, 1995.
46. WILLIAMS, K. P. AND SHOELSON, S. E.: A photoaffinity scan maps regions of the p85 SH2 domain involved in phosphoprotein binding. J. Biol. Chem. 268: 5361-5364, 1993.
47. YAMIN, M., GORN, A. H., FLANNERY, M. R., JENKINS, N. A., GILBERT, D. J., COPELAND, N. G., TAPP. D. R., KRANE, S. M. AND GOLDRING. S. R.: Cloning and characterization of a mouse brain calcitonin receptor complementary deoxyribonucleic acid and mapping of the calcitonin receptor gene. Endocrinology 6: 2635-2643, 1994.
48. ZHOU, A. T., BESSALLE R., BISELLO A., NAKAMOTO C., ROSENBLATT, M., SUVA, L. J. AND CHOREV M.: Direct mapping of an agonist-binding domain within the parathyroid hormone/parathyroid hormone-related protein receptor by photoaffinity crosslinking. Proc. Natl. Acad. Sci. U.S.A. 94: 3644-3649, 1997.